TRAVECTA Trademark

Trademark Overview

On Wednesday, January 29, 2020, a trademark application was filed for TRAVECTA with the United States Patent and Trademark Office. The USPTO has given the TRAVECTA trademark a serial number of 88776927. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 28, 2022. This trademark is owned by Travecta Therapeutics Pte Ltd.. The TRAVECTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of disorders and conditions of the central nervous system; pharmaceutical preparations, namely, therapeutic delivery agents for the treatment of disorders and conditions of the central nervous system; pharmaceutical products for the prevention and treatment of cancer
travecta

General Information

Serial Number88776927
Word MarkTRAVECTA
Filing DateWednesday, January 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of disorders and conditions of the central nervous system; pharmaceutical preparations, namely, therapeutic delivery agents for the treatment of disorders and conditions of the central nervous system; pharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTravecta Therapeutics Pte Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 118264
SG
Party NameTravecta Therapeutics Pte Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 118264
SG

Trademark Events

Event DateEvent Description
Monday, February 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 7, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021SOU EXTENSION 2 GRANTED
Tuesday, July 27, 2021SOU EXTENSION 2 FILED
Tuesday, July 27, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 26, 2021SOU EXTENSION 1 GRANTED
Tuesday, January 26, 2021SOU EXTENSION 1 FILED
Tuesday, January 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020ASSIGNED TO LIE
Wednesday, April 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 22, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, April 22, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 22, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, April 22, 2020EXAMINERS AMENDMENT -WRITTEN
Saturday, April 18, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 1, 2020NEW APPLICATION ENTERED

Related Keywords

travecta pharmaceutical preparations treatment system central nervous conditions namely disorders prevention